SCHEMBL16626713

SCHEMBL16626713

CNCc1cn(S(=O)(=O)c2cccnc2)c2cc(Nc3c(F)cc(Br)cc3F)ccc12

nearest known ligand 0.37

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
IDE P14735 1/20 0.37
HTR6 P50406 13/20 0.36
PDE4A P27815 1/20 0.33
PDE4B Q07343 1/20 0.33
PDE4C Q08493 1/20 0.33
PDE4D Q08499 1/20 0.33
HTT P42858 1/20 0.33
TBXAS1 P24557 1/20 0.33
CYP19A1 P11511 1/20 0.32
FGFR4 P22455 1/20 0.32
MAP2K7 O14733 1/20 0.31
MAP2K4 P45985 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL16618818 0.99 IDE (0.36) IDEHTR6PDE4APDE4BPDE4C
SCHEMBL16626689 0.96 IDE (0.36) IDEHTR6PDE4APDE4BPDE4C
Hydrochloric Acid SCHEMBL16619148 0.95 IDE (0.35) IDEHTR6PDE4APDE4BPDE4C
SCHEMBL16626705 0.93 IDE (0.38) IDEHTR6PDE4APDE4BPDE4C
Hydrochloric Acid SCHEMBL16619146 0.92 IDE (0.37) IDEHTR6PDE4APDE4BPDE4C
SCHEMBL17971528 0.92 IDE (0.38) IDEHTR6PDE4APDE4BPDE4C
SCHEMBL16626691 0.91 HTT (0.38) IDEHTR6PDE4APDE4BPDE4C
Hydrochloric Acid SCHEMBL16618777 0.91 IDE (0.38) IDEHTR6PDE4APDE4BPDE4C
SCHEMBL16626463 0.91 IDE (0.36) IDEHTR6PDE4APDE4BPDE4C
Hydrochloric Acid SCHEMBL16619096 0.91 HTT (0.38) IDEHTR6PDE4APDE4BPDE4C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3052484-B1 SULFONYLINDOLE DERIVATIVES AND METHOD FOR PREPARING THE SAME DAE WOONG PHARMA (KR) 2018-03-21 EP claimed
EP-3052484-B1 SULFONYLINDOLE DERIVATIVES AND METHOD FOR PREPARING THE SAME DAE WOONG PHARMA (KR) 2018-03-21 EP disclosed
US-9676714-B2 Sulfonylindole derivatives and method for preparing the same DAEWOONG PHARMACEUTICAL CO., LTD. (KR) 2017-06-13 US disclosed
US-9676714-B2 Sulfonylindole derivatives and method for preparing the same DAEWOONG PHARMACEUTICAL CO., LTD. (KR) 2017-06-13 US disclosed
US-20160221946-A1 SULFONYLINDOLE DERIVATIVES AND METHOD FOR PREPARING THE SAME DAEWOONG PHARMACEUTICAL CO., LTD. (KR) 2016-08-04 US disclosed
US-20160221946-A1 SULFONYLINDOLE DERIVATIVES AND METHOD FOR PREPARING THE SAME DAEWOONG PHARMACEUTICAL CO., LTD. (KR) 2016-08-04 US disclosed
WO-2015050412-A1 SULFONYLINDOLE DERIVATIVES AND METHOD FOR PREPARING THE SAME DAEWOONG PHARMACEUTICAL CO., LTD. (KR) 2015-04-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160221946-A1 SULFONYLINDOLE DERIVATIVES AND METHOD FOR PREPARING THE SAME GIPR, PGC, SI IDE 2586/4885HTR6 166/4885PDE4A 2460/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.